Frontage Labs

Frontage & Tigermed ASCO Symposium & Dinner Reception

chicago architecture center

You are cordially invited to our symposium, hosted by Frontage and Tigermed!


Sunday, June 4, 6 – 9 pm CDT


Chicago Architecture Center, 111 East Wacker Drive Chicago, IL 60601

About this Event

Join Frontage and Tigermed at this ASCO Symposium to learn about the various solutions supporting the accelerated delivery of oncology drugs to the market, as well as the trends in biomarker discovery for oncology and precision medicine.

[IMPORTANT] Please Read: This is an invitation-only event, and we can only accommodate a set number of guests in the venue. Unfortunately, no plus ones or additional guests are permitted. If you register to attend, and can no longer make it, please let us know no later than 9:00 AM on Tuesday, May 30th. Thank you!


6:00 PM – 7:00 PM: Cocktail Reception

7:00 PM – 7:15 PM: Dinner Seating

7:15 PM – 7:30 PM: Opening Remarks

7:30 PM – 7:50 PM: Industry Speaker: Jialu Liu

Jialu Liu, Associate Director, Biologics Services, Frontage Laboratories, Inc. Topic: Biomarker Bioanalysis in Oncology Drug Development and Personalized Medicine Summary: Technological advancement and the discovery of various biomarkers have made personalized/precision medicine a reality. Biomarkers are used in clinical oncology to help evaluate benefits that can be achieved through targeted therapy. In this precision oncology era, more and more clinical trials are now driven by biomarkers, with an overarching objective to optimize and personalize disease management. The inclusion of companion biomarkers has become mandatory in all new drug trials that are conducted for targeted therapies in the oncological field.

7:55 PM – 8:15 PM: Keynote Speaker: Britney Winterberger

Britney Winterberger, Senior Clinical Project Director, Multi Regional, Oncology Services, Tigermed Topic: Optimizing Clinical Development of Your Oncology Asset: Strategies for Cost-Effective, High-Quality, and Flexible Delivery Summary: In this presentation, we will share our insights and solutions to help bring oncology assets to market as fast as possible, while ensuring quality, and being considerate of cost. The audience will benefit from our experience in this field, enabling them to make informed decisions in their quest to bring effective oncology treatments to patients as quickly and efficiently as possible.

8:15 PM – 8:25 PM: Closing Remarks

8:25 PM – 9:00 PM: Q&A